IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,211,000 | +72.8% | 57,225 | +32.0% | 0.07% | +228.6% |
| Q4 2017 | $701,000 | -84.5% | 43,350 | -86.6% | 0.02% | -85.3% |
| Q3 2017 | $4,520,000 | +111.3% | 323,320 | +33.5% | 0.14% | +146.6% |
| Q2 2017 | $2,139,000 | -9.1% | 242,260 | -33.4% | 0.06% | -14.7% |
| Q1 2017 | $2,353,000 | +171.7% | 363,755 | +54.1% | 0.07% | +195.7% |
| Q4 2016 | $866,000 | +29.8% | 236,055 | +15.0% | 0.02% | +27.8% |
| Q3 2016 | $667,000 | +158.5% | 205,345 | +84.9% | 0.02% | +125.0% |
| Q2 2016 | $258,000 | – | 111,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |